Complex interactions between the major and minor envelope proteins of equine arteritis virus determine its tropism for equine CD3+ T lymphocytes and CD14+ monocytes

Journal of Virology

Volumn 84, Issue 10, 2010, Pages 4898-4911

  Go, Yun Young ^a   Zhang, Jianqiang ^a   Timoney, Peter J ^a   Cook, R Frank ^a   Horohov, David W ^a   Balasuriya, Udeni B R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CELL RECEPTOR; ENVELOPE PROTEIN; GLYCOPROTEIN GP 2; GLYCOPROTEIN GP3; GLYCOPROTEIN GP4; GLYCOPROTEIN GP5; GLYCOPROTEIN M; LIVE VACCINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERITIS; ARTICLE; CD3+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; EQUINE VIRAL ARTERITIS VIRUS; FLOW CYTOMETRY; HORSE; INFECTION SENSITIVITY; MACROPHAGE; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; SEQUENCE ANALYSIS; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANTIGENS, CD14; ANTIGENS, CD3; ARTERITIS VIRUS, EQUINE; CELLS, CULTURED; ENDOTHELIAL CELLS; HORSES; MONOCYTES; PROTEIN INTERACTION MAPPING; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS; VIRAL TROPISM; VIRUS ATTACHMENT;

EQUIDAE; EQUINE ARTERITIS VIRUS;

EID: 77951462585     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02743-09     Document Type: Article

References (68)

1. Balasuriya, U. B., J. F. Evermann, J. F. Hedges, A. J. McKeirnan, J. Q. Mitten, J. C. Beyer, W. H. McCollum, P. J. Timoney, and N. J. MacLachlan. 1998. Serologic and molecular characterization of an abortigenic strain of equine arteritis virus isolated from infective frozen semen and an aborted equine fetus. J. Am. Vet. Med. Assoc. 213:1586-1589.
2. Balasuriya, U. B., H. W. Heidner, N. L. Davis, H. M. Wagner, P. J. Hullinger, J. F. Hedges, J. C. Williams, R. E. Johnston, W. David Wilson, I. K. Liu, and N. James MacLachlan. 2002. Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses. Vaccine 20:1609-1617.
3. Balasuriya, U. B., C. M. Leutenegger, J. B. Topol, W. H. McCollum, P. J. Timoney, and N. J. MacLachlan. 2002. Detection of equine arteritis virus by real-time TaqMan reverse transcription-PCR assay. J. Virol. Methods 101:21-28.
4. Balasuriya, U. B., and N. J. MacLachlan. 2004. The immune response to equine arteritis virus: potential lessons for other arteriviruses. Vet. Immunol. Immunopathol. 102:107-129.
5. Balasuriya, U. B., E. J. Snijder, H. W. Heidner, J. Zhang, J. C. Zevenhoven-Dobbe, J. D. Boone, W. H. McCollum, P. J. Timoney, and N. J. Maclachlan. 2007. Development and characterization of an infectious cDNA clone of the virulent Bucyrus strain of equine arteritis virus. J. Gen. Virol. 88:918-924.
6. Balasuriya, U. B., E. J. Snijder, L. C. van Dinten, H. W. Heidner, W. D. Wilson, J. F. Hedges, P. J. Hullinger, and N. J. MacLachlan. 1999. Equine arteritis virus derived from an infectious cDNA clone is attenuated and genetically stable in infected stallions. Virology 260:201-208.
7. Blanchard-Channell, M., P. F. Moore, and J. L. Stott. 1994. Characterization of monoclonal antibodies specific for equine homologues of CD3 and CD5. Immunology 82:548-554. (Pubitemid 24263380)
8. Brinton, M. A. 2001. Host factors involved in West Nile virus replication. Ann. N. Y. Acad. Sci. 951:207-219.
9. Brinton, M. A., and A. A. Perelygin. 2003. Genetic resistance to flaviviruses. Adv. Virus Res. 60:43-85.
10. Bryans, J. T., M. E. Crowe, E. R. Doll, and W. H. McCollum. 1957. Isolation of a filterable agent causing arteritis of horses and abortion by mares; its differentiation from the equine abortion (influenza) virus. Cornell Vet. 47:3-41.
11. Bryans, J. T., E. R. Doll, and R. E. Knappenberger. 1957. An outbreak of abortion caused by the equine arteritis virus. Cornell Vet. 47:69-75.
12. Cavanagh, D. 1997. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch. Virol. 142:629-633.
13. Claros, M. G., and G. von Heijne. 1994. TopPred II: an improved software for membrane protein structure predictions. Comput. Appl. Biosci. 10:685-686.
14. Crawford, T. B., and J. B. Henson. 1972. Viral arteritis of horses. Adv. Exp. Med. Biol. 22:175-183.
15. Das, P. B., P. X. Dinh, I. H. Ansari, M. de Lima, F. A. Osorio, and A. K. Pattnaik. 2010. The minor envelope glycoproteins GP2a and GP4 of porcine reproductive and respiratory syndrome virus interact with the receptor CD163. J. Virol. 84:1731-1740.
16. Del Piero, F. 2000. Equine viral arteritis. Vet. Pathol. 37:287-296.
17. Del Piero, F., P. A. Wilkins, J. W. Lopez, A. L. Glaser, E. J. Dubovi, D. H. Schlafer, and D. H. Lein. 1997. Equine viral arteritis in newborn foals: clinical, pathological, serological, microbiological and immunohistochemical observations. Equine Vet. J. 29:178-185. (Pubitemid 127516755)
18. de Vries, A. A., S. M. Post, M. J. Raamsman, M. C. Horzinek, and P. J. Rottier. 1995. The two major envelope proteins of equine arteritis virus associate into disulfide-linked heterodimers. J. Virol. 69:4668-4674.
19. de Vries, A. A., M. J. Raamsman, H. A. van Dijk, M. C. Horzinek, and P. J. Rottier. 1995. The small envelope glycoprotein (GS) of equine arteritis virus folds into three distinct monomers and a disulfide-linked dimer. J. Virol. 69:3441-3448.
20. Doll, E. R., J. T. Bryans, J. C. Wilson, and W. H. McCollum. 1968. Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney. Cornell Vet. 48:497-524.
21. Fukunaga, Y., H. Imagawa, E. Tabuchi, and Y. Akiyama. 1981. Clinical and virological findings on experimental equine viral arteritis in horses. Bull. Equine Res. Inst. 18:110-118.
22. Glaser, A. L., A. A. de Vries, P. J. Rottier, M. C. Horzinek, and B. Colenbrander. 1996. Equine arteritis virus: a review of clinical features and management aspects. Vet. Q. 18:95-99.
23. Golnik, W., Z. Michalska, and T. Michalak. 1981. Natural equine viral arteritis in foals. Schweiz. Arch. Tierheilkd. 123:523-533.
24. Harry, T. O., and W. H. McCollum. 1981. Stability of viability and immunizing potency of lyophilized, modified equine arteritis live-virus vaccine. Am. J. Vet. Res. 42:1501-1505.
25. Hedges, J. F., U. B. Balasuriya, and N. J. MacLachlan. 1999. The open reading frame 3 of equine arteritis virus encodes an immunogenic glycosylated, integral membrane protein. Virology 264:92-98.
26. Hedges, J. F., C. D. Demaula, B. D. Moore, B. E. McLaughlin, S. I. Simon, and N. J. MacLachlan. 2001. Characterization of equine E-selectin. Immunology 103:498-504.
27. Ibrahim, S., and F. Steinbach. 2007. Non-HLDA8 animal homologue section anti-leukocyte mAbs tested for reactivity with equine leukocytes. Vet. Immunol. Immunopathol. 119:81-91.
28. Johnson, B., C. Baldwin, P. Timoney, and R. Ely. 1991. Arteritis in equine fetuses aborted due to equine viral arteritis. Vet. Pathol. 28:248-250.
29. Jones, D. T. 2007. Improving the accuracy of transmembrane protein topology prediction using evolutionary information. Bioinformatics 23:538-544.
30. Jones, D. T., W. R. Taylor, and J. M. Thornton. 1994. A model recognition approach to the prediction of all-helical membrane protein structure and topology. Biochemistry 33:3038-3049.
31. Krogh, A., B. Larsson, G. von Heijne, and E. L. Sonnhammer. 2001. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305:567-580.
32. Lu, Z., A. Branscum, K. M. Shuck, J. Zhang, E. Dubovi, P. J. Timoney, and U. B. Balasuriya. 2008. Comparison of two real-time reverse transcription polymerase chain reaction assays for the detection of equine arteritis virus nucleic acid in equine semen and tissue culture fluid. J. Vet. Diagn. Invest. 20:147-155.
33. Lunn, D. P., M. A. Holmes, D. F. Antczak, N. Agerwal, J. Baker, S. Bendali-Ahcene, M. Blanchard-Channell, K. M. Byrne, K. Cannizzo, W. Davis, M. J. Hamilton, D. Hannant, T. Kondo, J. H. Kydd, M. C. Monier, P. F. Moore, T. O'Neil, B. R. Schram, A. Sheoran, J. L. Stott, T. Sugiura, and K. E. Vagnoni. 1998. Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995. Vet. Immunol. Immunopathol. 62:101-143.
34. Lunn, D. P., M. A. Holmes, and W. P. Duffus. 1991. Three monoclonal antibodies identifying antigens on all equine T lymphocytes, and two mutually exclusive T-lymphocyte subsets. Immunology 74:251-257.
35. MacLachlan, N. J., U. B. Balasuriya, P. V. Rossitto, P. A. Hullinger, J. F. Patton, and W. D. Wilson. 1996. Fatal experimental equine arteritis virus infection of a pregnant mare: immunohistochemical staining of viral antigens. J. Vet. Diagn. Invest. 8:367-374.
36. Mayall, S., E. Siedek, and A. S. Hamblin. 2001. The anti-human CD21 antibody, BU33, identifies equine B cells. J. Comp. Pathol. 124:83-87.
37. McCollum, W. H. 1969. Development of a modified virus strain and vaccine for equine viral arteritis. J. Am. Vet. Med. Assoc. 155:318-322.
38. McCollum, W. H. 1970. Vaccination for equine viral arteritis, p.143-151. In Equine infectious diseases. II. Proceedings of the Second International Conference on Equine Infectious Diseases, Paris 1969. Karger, Basel, Switzerland.
39. McCollum, W. H., E. R. Doll, and J. C. Wilson. 1961. The recovery of virus from horses with experimental cases of equine arteritis using monolayer cell cultures of rabbit kidney. Am. J. Vet. Res. 23:465-469.
40. McCollum, W. H., E. R. Doll, J. C. Wilson, and C. B. Johnson. 1961. Propagation of equine arteritis virus in monolayer cultures of equine kidney. Am. J. Vet. Res. 22:731-735.
41. McCollum, W. H., E. R. Doll, J. C. Wilson, and J. Cheatham. 1962. Isolation and propagation of equine arteritis virus in monolayer cell cultures of rabbit kidney. Cornell Vet. 52:452-458.
42. McCollum, W. H., M. E. Prickett, and J. T. Bryans. 1971. Temporal distribution of equine arteritis virus in respiratory mucosa, tissues and body fluids of horses infected by inhalation. Res. Vet. Sci. 12:459-464.
43. McCollum, W. H., and P. J. Timoney. 1999. Experimental observation on the virulence of isolates of equine arteritis virus. R&W Publications (Newmarket) Limited, Newmarket, United Kingdom.
44. McCollum, W. H., and P. J. Timoney. 1984. The pathogenic qualities of the 1984 strain of equine arteritis virus, p. 34-84. In Grayson Foundation International Conference of Thoroughbred Breeders Organizations, Ireland 1984.
45. McCollum, W. H., P. J. Timoney, J. W. Lee, Jr., P. L. Habacker, U. B. R. Balasuriya, and N. J. MacLachlan. 1999. Features of an outbreak of equine viral arteritis on a breeding farm associated with abortion and fatal interstitial pneumonia in neonatal foals. R&W Publications (Newmarket) Limited, Newmarket, United Kingdom.
46. Molenkamp, R., H. van Tol, B. C. Rozier, Y. van der Meer, W. J. Spaan, and E. J. Snijder. 2000. The arterivirus replicase is the only viral protein required for genome replication and subgenomic mRNA transcription. J. Gen. Virol. 81:2491-2496.
47. Moore, B. D., U. B. Balasuriya, J. F. Hedges, and N. J. MacLachlan. 2002. Growth characteristics of a highly virulent, a moderately virulent, and an avirulent strain of equine arteritis virus in primary equine endothelial cells are predictive of their virulence to horses. Virology 298:39-44.
48. Moore, B. D., U. B. Balasuriya, J. L. Watson, C. M. Bosio, R. J. MacKay, and N. J. MacLachlan. 2003. Virulent and avirulent strains of equine arteritis virus induce different quantities of TNF-alpha and other proinflammatory cytokines in alveolar and blood-derived equine macrophages. Virology 314:662-670.
49. Patton, J. F., U. B. Balasuriya, J. F. Hedges, T. M. Schweidler, P. J. Hullinger, and N. J. MacLachlan. 1999. Phylogenetic characterization of a highly attenuated strain of equine arteritis virus from the semen of a persistently infected standardbred stallion. Arch. Virol. 144:817-827.
50. Plagemann, P. G., and V. Moennig. 1992. Lactate dehydrogenase-elevating virus, equine arteritis virus, and simian hemorrhagic fever virus: a new group of positive-strand RNA viruses. Adv. Virus Res. 41:99-192.
51. Prickett, M. E., W. H. McCollum, and J. T. Bryans. 1972. The gross and microscopic pathology observed in horses experimentally infected with the equine arteritis virus, p. 265-272. In Equine infectious diseases. III. Proceedings of the Third International Conference on Equine Infectious Diseases, Paris 1972. Karger, Basel, Switzerland.
52. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497.
53. Senne, D. A., J. E. Pearson, and E. A. Carbrey. 1985. Equine viral arteritis: a standard procedure for the virus neutralization test and comparison of results of a proficiency test performed at five laboratories, p. 29-34. In Proceedings of the 89th Annual Meeting of the United States Animal Health Association. United States Animal Health Association, St. Joseph, MO.
54. Snijder, E. J., J. C. Dobbe, and W. J. Spaan. 2003. Heterodimerization of the two major envelope proteins is essential for arterivirus infectivity. J. Virol. 77:97-104.
55. Snijder, E. J., and J. J. Meulenberg. 1998. The molecular biology of arteriviruses. J. Gen. Virol. 79:961-979.
56. Snijder, E. J., and W. J. Spaan. 2006. Arteriviruses, p. 1337-1355. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
57. Snijder, E. J., H. van Tol, K. W. Pedersen, M. J. Raamsman, and A. A. de Vries. 1999. Identification of a novel structural protein of arteriviruses. J. Virol. 73:6335-6345. (Pubitemid 29327810)
58. Timoney, P. J., and W. H. McCollum. 1993. Equine viral arteritis. Vet. Clin. North Am. Equine Pract. 9:295-309.
59. Timoney, P. J., N. W. Umphenour, and W. H. McCollum. 1988. Safety evaluation of commercial modified live equine arteritis virus vaccine for use in stallions, p. 19-27. In Equine infectious diseases. V. Proceedings of the Fifth International Conference on Equine Infectious Diseases, Lexington 1987. Karger, Basel, Switzerland.
60. Vaala, W. E., A. N. Hamir, E. J. Dubovi, P. J. Timoney, and B. Ruiz. 1992. Fatal, congenitally acquired infection with equine arteritis virus in a neonatal thoroughbred. Equine Vet. J. 24:155-158.
61. van Aken, D., J. Zevenhoven-Dobbe, A. E. Gorbalenya, and E. J. Snijder. 2006. Proteolytic maturation of replicase polyprotein pp1a by the nsp4 main proteinase is essential for equine arteritis virus replication and includes internal cleavage of nsp7. J. Gen. Virol. 87:3473-3482.
62. Wagner, H. M., U. B. Balasuriya, and N. J. MacLachlan. 2003. The serologic response of horses to equine arteritis virus as determined by competitive enzyme-linked immunosorbent assays (c-ELISAs) to structural and nonstructural viral proteins. Comp. Immunol. Microbiol. Infect. Dis. 26:251-260.
63. Wieringa, R., A. A. De Vries, S. M. Post, and P. J. Rottier. 2003. Intra- and intermolecular disulfide bonds of the GP2b glycoprotein of equine arteritis virus: relevance for virus assembly and infectivity. J. Virol. 77:12996-13004. (Pubitemid 37494295)
64. Wieringa, R., A. A. de Vries, M. J. Raamsman, and P. J. Rottier. 2002. Characterization of two new structural glycoproteins, GP(3) and GP(4), of equine arteritis virus. J. Virol. 76:10829-10840.
65. Wieringa, R., A. A. de Vries, and P. J. Rottier. 2003. Formation of disulfide-linked complexes between the three minor envelope glycoproteins (GP2b, GP3, and GP4) of equine arteritis virus. J. Virol. 77:6216-6226. (Pubitemid 36588392)
66. Zhang, J., Y. Y. Go, N. J. MacLachlan, B. J. Meade, P. J. Timoney, and U. B. Balasuriya. 2008. Amino acid substitutions in the structural or nonstructural proteins of a vaccine strain of equine arteritis virus are associated with its attenuation. Virology 378:355-362.
67. Zhang, J., P. J. Timoney, N. J. MacLachlan, W. H. McCollum, and U. B. Balasuriya. 2008. Persistent equine arteritis virus infection in HeLa cells. J. Virol. 82:8456-8464.
68. Ziebuhr, J., E. J. Snijder, and A. E. Gorbalenya. 2000. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J. Gen. Virol. 81:853-879.